FDA.reportPublic FDA data

Ticovac 2.4 MCG per 0.5 ML Prefilled Syringe

RxCUI
2583650
RxNorm name
Ticovac 2.4 MCG per 0.5 ML Prefilled Syringe
Display name
Ticovac 2.4 MCG per 0.5 ML Prefilled Syringe
Full name
Ticovac 2.4 MCG per 0.5 ML Prefilled Syringe
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:23

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
125740TicovacTick-Borne Encephalitis Vaccine351(a)Rx2026-09-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
da102644-62a9-41c2-8a91-6fc19a03e6f1TICOVAC 2.4 MCG in 0.5 ML Prefilled Syringe [PSN] · 0.5 ML tick-borne encephalitis purified antigen 0.0048 MG/ML Prefilled Syringe [Ticovac] [SBD] · 0.5 ML Ticovac 0.0048 MG/ML Prefilled Syringe [SY] · Ticovac 2.4 MCG per 0.5 ML Prefilled Syringe [SY]47These highlights do not include all the information needed to use TICOVAC safely and effectively. See full prescribing information for TICOVAC. TICOVAC (Tick-Borne Encephalitis Vaccine), Suspension for intramuscular injection Initial U.S. Approval: 202120260317